Advanced Melanoma: Navigating Resistance, Toxicities, and Emerging Therapies
A Special Issue of Clinics and Practice (ISSN 2039-7283).
Deadline for manuscript submissions: 31 August 2027 | Viewed by 32
Editors
2. University Hospitals Seidman Cancer Center, Cleveland, OH 44103, USA
3. Case Comprehensive Cancer Center, Cleveland, OH 44106, USA
Interests: checkpoint inhibitors; cell therapy; melanoma; T-cell receptor therapy; oncolytic virus; intratumoral therapy; interleukin; immune-related adverse effects; immunomodulation
Interests: skin cancer; melanoma; acral lentiginous melanoma; uveal melanoma; mucosal melanoma; squamous cell carcinoma
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Melanoma is the deadliest among all skin cancers. Fortunately, the introduction of immunotherapy has improved outcomes for patients with melanoma over the last decade. However, the treatment paradigm has evolved rapidly, creating controversy and unique opportunities in the treatment of patients with advanced melanoma. Patients with melanoma continue to face challenges in terms of determining the right fit for treatment, immunotherapy-related side effects, post-immunotherapy failure treatment choices, access to clinical trials, and social barriers to expert care, among others. This Special Issue aims to present and disseminate recent developments in the treatment of patients with localized and advanced melanoma. As treatment choices for patients with melanoma evolve, along with recent advances in relapse prediction models, treatment beyond anti-PD1 failure, and the introduction of new biologics for immunotherapy-related side effects, this Issue serves as a timely avenue for disseminating research in this area.
We welcome contributions to this Issue addressing recent developments in therapeutic options, management of immunotherapy-related adverse events, and barriers to accessing care for patients diagnosed with localized, advanced resectable, and metastatic melanoma. The topics of interest will include, but are not limited to:
- Treatment options for patients with melanoma with brain metastasis;
- Management of patients with anti-PD1 refractory melanoma;
- Utility of Liquid biopsy and circulating tumor DNA in the management of patients with advanced melanoma;
- Strategies to reduce the occurrence of melanoma/skin cancers.
Dr. Ankit Mangla
Dr. Gino K. In
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Clinics and Practice is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- metastatic melanoma
- brain metastasis
- circulating tumor DNA
- immunotherapy-related side effects
- anti-PD1 refractory melanoma
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
